185 related articles for article (PubMed ID: 12060130)
1. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience.
Smith BD; Jones RJ; Lee SM; Piantadosi S; Vala MS; Fuller D; Gore SD; Noga SJ; O'Donnell PV; Braine H; Vogelsang GB; Fuchs EJ; Flinn IW; Brodsky RA; Ambinder RF; Miller CB
Br J Haematol; 2002 Jun; 117(4):907-13. PubMed ID: 12060130
[TBL] [Abstract][Full Text] [Related]
2. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.
Miller CB; Rowlings PA; Zhang MJ; Jones RJ; Piantadosi S; Keating A; Armitage JO; Calderwood S; Harris RE; Klein JP; Lazarus HM; Linker CA; Sobocinski KA; Weisdorf D; Horowitz MM
Exp Hematol; 2001 Nov; 29(11):1336-46. PubMed ID: 11698130
[TBL] [Abstract][Full Text] [Related]
3. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report.
Linker CA; Ries CA; Damon LE; Rugo HS; Wolf JL
Bone Marrow Transplant; 1998 Nov; 22(9):865-72. PubMed ID: 9827814
[TBL] [Abstract][Full Text] [Related]
4. Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.
Demirer T; Gooley T; Buckner CD; Petersen FB; Lilleby K; Rowley S; Sanders J; Storb R; Appelbaum FR; Bensinger WI
Bone Marrow Transplant; 1995 Jun; 15(6):907-13. PubMed ID: 7581090
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations.
Yeager AM; Rowley SD; Kaizer H; Santos GW
Am J Pediatr Hematol Oncol; 1990; 12(3):245-56. PubMed ID: 2240470
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia.
Dusenbery KE; Daniels KA; McClure JS; McGlave PB; Ramsay NK; Blazar BR; Neglia JP; Kersey JH; Woods WG
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):119-28. PubMed ID: 7995742
[TBL] [Abstract][Full Text] [Related]
7. Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission.
Tiedemann K; Waters KD; Tauro GP; Tucker D; Ekert H
Blood; 1993 Dec; 82(12):3730-8. PubMed ID: 8260710
[TBL] [Abstract][Full Text] [Related]
8. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
[TBL] [Abstract][Full Text] [Related]
9. Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up.
Ball ED; Wilson J; Phelps V; Neudorf S
Bone Marrow Transplant; 2000 Apr; 25(8):823-9. PubMed ID: 10808202
[TBL] [Abstract][Full Text] [Related]
10. One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience.
Laporte JP; Douay L; Lopez M; Labopin M; Jouet JP; Lesage S; Stachowiak J; Fouillard L; Isnard F; Noel-Walter MP
Blood; 1994 Dec; 84(11):3810-8. PubMed ID: 7949137
[TBL] [Abstract][Full Text] [Related]
11. Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institution.
Gorin NC; Labopin M; Laporte JP; Douay L; Lopez M; Lesage S; Fouillard L; Isnard F; Jouet JP; Bellal N; Perot C; Van Den Akker J; Bauters F; Najman A
Exp Hematol; 1999 Dec; 27(12):1822-30. PubMed ID: 10641600
[TBL] [Abstract][Full Text] [Related]
12. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties.
Burnett AK; Goldstone AH; Stevens RM; Hann IM; Rees JK; Gray RG; Wheatley K
Lancet; 1998 Mar; 351(9104):700-8. PubMed ID: 9504514
[TBL] [Abstract][Full Text] [Related]
13. Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).
Gorin NC; Labopin M; Meloni G; Korbling M; Carella A; Herve P; Burnett A; Rizzoli V; Alessandrino EP; Bjorkstrand B
Leukemia; 1991 Oct; 5(10):896-904. PubMed ID: 1835746
[TBL] [Abstract][Full Text] [Related]
14. Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia.
Chao NJ; Stein AS; Long GD; Negrin RS; Amylon MD; Wong RM; Forman SJ; Blume KG
Blood; 1993 Jan; 81(2):319-23. PubMed ID: 8422458
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
16. Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.
Yeager AM; Vogelsang GB; Jones RJ; Farmer ER; Altomonte V; Hess AD; Santos GW
Blood; 1992 Jun; 79(11):3031-5. PubMed ID: 1586747
[TBL] [Abstract][Full Text] [Related]
17. 4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia.
Rizzieri DA; Talbot JT; Long GD; Vredenburgh JJ; Gasparetto C; Smith CS; Colvin MO; Adams D; Morris A; Dodge R; Loftis J; Waters-Pick B; Reese M; Carawan H; Koh LP; Chao NJ
Biol Blood Marrow Transplant; 2003 Mar; 9(3):183-8. PubMed ID: 12652469
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission.
Lenarsky C; Weinberg K; Petersen J; Nolta J; Brooks J; Annett G; Kohn D; Parkman R
Bone Marrow Transplant; 1990 Dec; 6(6):425-9. PubMed ID: 2097012
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia.
Grigg AP; Szer J; Beresford J; Dodds A; Bradstock K; Durrant S; Schwarer AP; Hughes T; Herrmann R; Gibson J; Arthur C; Matthews J
Br J Haematol; 1999 Nov; 107(2):409-18. PubMed ID: 10583235
[TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E
Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
